It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Patients with chronic disorders like non-alcoholic fatty liver disease (NAFLD) face important challenges adhering to diagnostic and treatment tracks. As NAFLD increases, the need to incentivize health-seeking behaviors grows. No evidence-based interventions to address this gap exist. The aim of the study was to estimate the effect of providing increasing levels of diagnostic information on medical care-seeking in adults newly diagnosed with NAFLD. We randomly assigned adults with a sonographic diagnosis of NAFLD at a check-up unit in Mexico to one of five groups. All groups received medical consultation. A: no further interventions; B: received multimedia educational material (MEM); C: MEM + NAFLD-fibrosis-score (NFS); D: MEM + transient elastography (TE); E: MEM + NFS + TE. 1209 participants were randomized, follow-up rate 91%; 82% male, BMI 30.5 ± 4 kg/m2. There were no differences in the proportion of patients undergoing further diagnostic evaluation of liver fibrosis (A 0.4%, E 0.4%, P-for-trend = 0.269). Groups who received more information sought specialized medical care more frequently: A 22%, E 30% (P-for-trend = 0.047). A trend to receive treatment was also observed at higher levels of information: A 26.7%, E 36.3% (P-for-trend = 0.134). Increasing the amount of diagnostic information seemed to increase patient’s health-seeking. Tailoring the communication of information obtained for diagnosis could help to increase health-seeking in chronic disease patients.
Trial registration: NCT01874249 (full date of first registration 11-06-2013).
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Medica Sur Clinic and Foundation, Obesity and Digestive Diseases Unit and Translational Research Unit, Mexico City, Mexico (GRID:grid.414741.3) (ISNI:0000 0004 0418 7407)
2 National Institute of Public Health, Center for Population Health Research, Cuernavaca, Mexico (GRID:grid.415771.1) (ISNI:0000 0004 1773 4764)
3 Instituto Mexicano del Seguro Social, Gastroenterology Department, Centro Medico Nacional La Raza, Mexico City, Mexico (GRID:grid.419157.f) (ISNI:0000 0001 1091 9430)
4 Medica Sur Clinic and Foundation, Translational Research Unit, Mexico City, Mexico (GRID:grid.414741.3) (ISNI:0000 0004 0418 7407)
5 Medica Sur Clinic and Foundation, Integral Diagnosis and Treatment Center, Mexico City, Mexico (GRID:grid.414741.3) (ISNI:0000 0004 0418 7407)
6 Medica Sur Clinic and Foundation, Radiology and Medical Imaging Unit, Mexico City, Mexico (GRID:grid.414741.3) (ISNI:0000 0004 0418 7407)